BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34179876)

  • 1. Acute on chronic heart failure-Which variations on B-type natriuretic peptide levels?
    Bettencourt P; Chora I; Silva F; Lourenço P; Peacock WF
    J Am Coll Emerg Physicians Open; 2021 Jun; 2(3):e12448. PubMed ID: 34179876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of mortality with Pro-BNP and precipitating factors of acute heart failure in patients presenting to a medical emergency of tertiary care hospital: an observational study from north India.
    Bhatia MS; Sharda SC; Attri R; Pannu AK; Dahiya N
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6459-6468. PubMed ID: 36196696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Hoes AW; van Veldhuisen DJ
    Am Heart J; 2006 May; 151(5):1012.e1-5. PubMed ID: 16644323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
    Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
    Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients.
    Kadri AN; Kaw R; Al-Khadra Y; Abuamsha H; Ravakhah K; Hernandez AV; Tang WHW
    Arch Med Sci; 2018 Aug; 14(5):1003-1009. PubMed ID: 30154881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms.
    Takashio S; Takahama H; Nishikimi T; Hayashi T; Nagai-Okatani C; Matsuo A; Nakagawa Y; Amano M; Hamatani Y; Okada A; Amaki M; Hasegawa T; Kanzaki H; Yasuda S; Kangawa K; Anzai T; Minamino N; Izumi C
    Open Heart; 2019; 6(2):e001072. PubMed ID: 31413847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of serial assessment of natriuretic peptides in the emergency department for patients with acute decompensated heart failure.
    Disomma S; Magrini L; Pittoni V; Marino R; Peacock WF; Maisel A
    Congest Heart Fail; 2008; 14(4 Suppl 1):21-4. PubMed ID: 18772629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide (BNP) levels and ethnic disparities in perceived severity of heart failure: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study of BNP levels and emergency department decision making in patients presenting with shortness of breath.
    Daniels LB; Bhalla V; Clopton P; Hollander JE; Guss D; McCullough PA; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Jesse R; Maisel A
    J Card Fail; 2006 May; 12(4):281-5. PubMed ID: 16679261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure.
    Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Januzzi JL; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Cohen-Solal A; Richards AM; Launay JM; Mebazaa A;
    JACC Heart Fail; 2015 Aug; 3(8):629-36. PubMed ID: 26251090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
    Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
    Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients.
    Park S; Cho GY; Kim SG; Hwang YI; Kang HR; Jang SH; Kim DG; Song YR; Bae YA; Jung KS
    Crit Care; 2009; 13(3):R70. PubMed ID: 19445682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
    Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
    Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
    Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.
    Di Somma S; Magrini L; Pittoni V; Marino R; Mastrantuono A; Ferri E; Ballarino P; Semplicini A; Bertazzoni G; Carpinteri G; Mulè P; Pazzaglia M; Shah K; Maisel A; Clopton P
    Crit Care; 2010; 14(3):R116. PubMed ID: 20550660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.